HOOD faces earnings on April 28 with short interest climbing and analysts sharply divided on valuation. Eleven price-target changes in two weeks reflect uncertainty about trading volumes and crypto momentum.
Short interest hit 4.59% of free float as of April 23, up 19.4% over the past month. Shares shorted climbed 8.3% over the past week to 36.1 million. Days to cover stands at just 1.01 per FINRA's latest settlement. Cost to borrow remains negligible at 0.37%, up modestly from 0.34% a week ago. Utilisation rose to 4.45%, still well below the 52-week high of 9.71%. The recent acceleration suggests some tactical short positioning ahead of the print.
The put-call ratio closed at 0.649 on April 24, sitting below the 20-day mean of 0.656 and registering a z-score of -0.56. This reflects a mild call bias. PCR has traded in a 0.51–0.74 range over the past year. Current levels suggest balanced sentiment with no extreme skew into the event.
Eight analysts cut price targets in April. JP Morgan lowered its neutral-rated target to $92 from $113 on April 23. Keybanc dropped its overweight target to $110 from $120 on April 21. Barclays slashed its overweight target to $89 from $124 on April 8. Mizuho raised its outperform target to $115 from $105 on April 20. Cantor Fitzgerald lifted its overweight target to $110 from $95 on April 21. The mean price target across firms is $101.15. Benzinga's bull case highlights 10% quarter-over-quarter volume growth in equities and options plus AI-driven cost savings. The bear case flags slowed platform growth and downward FY'26 revenue revisions to $5.3 billion.
P/E ratio stands at 33.4, down 2.96 points over the past week. P/B sits at 6.99, down 0.63 over seven days. The 30-day P/B move was +1.02, reflecting the stock's 22.6% rally over that span. Factor scores show EPS momentum ranking in the 13th percentile over 30 days and 14th over 90 days. EPS surprise ranks at the 54th percentile. Analyst recommendation differential ranks 48th.
Insiders sold $38.5 million net over the past 90 days. Co-founder Baiju Bhatt sold 188,486 shares between April 6 and April 16. CFO Shiv Verma sold 5,436 shares on April 15. Vanguard holds 10.6% and added 1.3 million shares in Q1. BlackRock holds 7.1% and added 4.5 million shares.
Robinhood last reported on February 10. Prior earnings fell on February 11, 2026 and multiple dates in late 2025. The stock has shown volatile post-earnings swings in past cycles.
No active ORTEX Alpha signals.
See the live data behind this article on ORTEX.
Open HOOD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
